GSK advances mRNA flu vaccine to phase 3 after positive results
(Alliance News) - GSK PLC on Tuesday said a phase 2 probe of its mRNA flu vaccine candidate showed positive results and that phase 3 trials will start this month.
LA OnlineU.S. business, markets & technology